AI assistant
Ipca Laboratories Ltd. — Capital/Financing Update 2020
Sep 2, 2020
61700_rns_2020-09-02_97c5d64e-c91d-4d87-a053-aff1c6e7773a.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
THRU ONLINE FILING
September 2, 2020
BSE Limited Phiroze Jeejeebhoy Towers 27[th] Floor, Dalal Street Mumbai 400 023
The National Stock Exchange of India Ltd. Exchange Plaza, 5[th] Fir, Plot # C/1 G Block, Bandra-Kurla Complex, Bandra (E), Mumbai 400 051.
Sub: Re-affirmation of CRISIL rating for Company's Rs. 50 crores commercial paper programme
This is to inform you that CRISIL has re-affirmed its rating for the Company's commercial paper programme:
IRS. 50 crores Commercial Paper I CRISIL A 1+ (Reaffirmed)
This is for your information and record.
This is for your information.
Thanking you
Yours faithfully For Ipca Laboratories Limited V~ - ~-
Harish P. Kamath Corporate Counsel & Company Secretary
Ipea Laboratories Ltd. www.ipea.com
125, Kandivli Industrial Estate, CTS No. 328, Kandivli (West), Mumbai 400 067 (Maharashtra), India I T: +91 2262105000 F:+91 22 62105005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India I T: +91 2266474444 E: [email protected] CIN: L24239MH 1949PLC007837